Human Tissue Authority

The regulator for human tissue and organs

Monitoring and Measuring Performance – Key Performance Indicators

Strand Objective Activity Performance indicator
Delivery Deliver a right touch programme of licensing, inspection and incident reporting, targeting our resources where there is most risk to public confidence and patient safety. Undertake a risk based inspection / audit programme 

180 site visits to take place during the business year across all sectors (year-to-date)

*the total number of inspections will be dependent on resources required to be redeployed for other activity

Delivery Be consistent and transparent in our decision-making and regulatory action, supporting those licence holders who are committed to achieving high quality and dealing firmly and fairly with those who do not comply with our standards. Take appropriate action for all regulatory non-compliances 100% of Corrective and Preventative Actions (CAPAs) implemented to address critical and major shortfalls are completed to the HTA's satisfaction within agreed timescales or further regulatory action implemented (reported monthly)
Delivery Be consistent and transparent in our decision-making and regulatory action, supporting those licence holders who are committed to achieving high quality and dealing firmly and fairly with those who do not comply with our standards. Make appropriately evidenced decisions to agreed quality standards 100% of non-panel cases turned around in line with the quality criteria set out in the standard operating procedure, and within five working days (average reported monthly)
Delivery Be consistent and transparent in our decision-making and regulatory action, supporting those licence holders who are committed to achieving high quality and dealing firmly and fairly with those who do not comply with our standards. Make appropriately evidenced decisions within agreed timeframes 100% of panel cases turned around in line with the quality criteria set out in the standard operating procedure, and within ten working days (average reported monthly)
Delivery Provide high quality advice and guidance in a timely way to support professionals, Government and the public in matters within our remit; Respond to enquiries in a timely way  At least 95% of enquiries are answered within ten working days of receipt, excluding body donation enquiries (reported monthly)
Development Make continuous improvements to our systems and processes to minimise waste or duplicated effort, or address areas of risk

PROJECT: 

Implementation of improvements to target areas of risk in the HA sector

Project RAG status remains amber or green during the course of the project (reported monthly)
Development Further plan, develop and implement an organisational change programme

PROGRAMME: 

Develop and implement a series of business cases for projects which will form the HTA’s organisational change programme

Individual project RAG status remains amber or green during the course of the project (once approved)
Development Provide an agile response to innovation and change in the sectors we regulate, making it clear how to comply with new and existing regulatory requirements

PROJECT: 

Develop a revised Code of Practice to provide practical guidance on the implementation of deemed consent for organ donation.

Project RAG status remains amber or green during the course of the project (reported monthly)

Completion of drafting (Q1)

Stakeholder consultation (Q2)

Parliamentary approval (Q3)
 

Deployment Manage and develop our people in line with the HTA’s People Strategy Reduce attrition rates through improved selection and targeted retention measures to retain staff Attrition rate measured monthly on a rolling annual basis (high risk if more than 18%) (reported quarterly)
Deployment Manage and develop our people in line with the People Strategy. Lead and advise on best recruitment procedures to maintain organisational capacity and capability Number of vacancies reported monthly (high risk if more than three vacancies) (reported quarterly)
Deployment Ensure the continued financial viability of the HTA while charging fair and transparent licence fees and providing value for money. Ensure that the HTA has sufficient financial resources to fund its regulatory and policy activity, whilst continuing to provide value for money to license fee payers through limiting growth in licence fees

Actual income versus budgeted income (reported monthly)

Actual spend versus budgeted spend (reported monthly);

Actual cash reserves versus required reserve of £1.8m (high risk if deficit is more than 10%) (reported monthly)
 

Deployment Ensure the continued financial viability of the HTA while charging fair and transparent licence fees and providing value for money. Ensure that the HTA has sufficient financial resources to fund its regulatory and policy activity, whilst continuing to provide value for money to license fee payers through limiting growth in licence fees

Annual fees are calculated to recover no more than the net cost of HTA activity (total costs less Department of Health Grant-in-Aid and devolved governments income) (reported quarterly)

Revisions to fees issued to stakeholders at least three months prior to implementation (reported quarterly)

 

Last updated on: 2 Jul 2019